Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: Basis for a vaccine for xenotransplantation?

Virology

Volumn 307, Issue 2, 2003, Pages 406-413

  Fiebig, Uwe ^a   Stephan, Oliver ^b   Kurth, Reinhard ^a   Denner, Joachim ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Epitope mapping; Neutralizing antibodies; Retroviruses; Vaccine; Xenotransplantation

Indexed keywords

ANTISERUM; NEUTRALIZING ANTIBODY; PROTEIN P15E; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTIBODY ISOLATION; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROVIRUS; SEQUENCE HOMOLOGY; VIRUS INFECTIVITY; VIRUS STRAIN; XENOTRANSPLANTATION;

ANIMALIA; CAPRA HIRCUS; GAMMARETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PORCINE ENDOGENOUS RETROVIRUS; SUIDAE;

EID: 0344405785     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00140-X     Document Type: Article

References (38)

1. Dai Y., Vaught T.D., Boone J., Chen S.H., Phelps C.J., Ball S., Monahan J.A., Jobst P.M., McCreath K.J., Lamborn A.E., Cowell-Lucero J.L., Wells K.D., Colman A., Polejaeva I.A., Ayares D.L. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20:(3):2002;251-255.
2. Deng Y., Tuch B., Rawlinson W. Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation. 70:(7):2000;1010-1016.
3. Denner J. Immunosuppression by oncogenic retroviridae. Zschiesche W. Modulation of the Immune Responsiveness by Infectious Agents. 1987;140-201 Fischer Verlag, Jena.
4. Denner J. Immunosuppression by retroviruses implications for xenotransplantation . Ann. N. Y. Acad. Sci. 862:1998;75-86.
5. Denner J., Norley S., Kurth R. The immunosuppressive peptide of HIV-1 functional domains and immune response in AIDS patients . AIDS. 8:(8):1994;1063-1072.
6. Denner J., Specke V., Schwendermann J., Tacke S. Porcine endogenous retroviruses (PERVs) adaptation to human cells and attempts to infect small animals and non-human primates . Ann. Transplant. 6:(3):2001;25-33.
7. Denner J., Specke V., Tacke S., Özel M. Porcine endogenous retroviruses (PERVs) diagnostic assays, adaptation to human cells and infection experiments with small animals and non-human primates . Tx Med. 14:2002;171-183.
8. Elder J.H., McGee J.S., Munson M., Houghten R.A., Kloetzer W., Bittle J.L., Grant C.K. Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies. J. Virol. 61:(1):1987;8-15.
9. Gao F., Bailes E., Robertson D., Chen Y., Rodenburg C., Michael S., Cummins L., Arthur L., Peeters M., Shaw G., Sharp P., Hahn B. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 397:(6718):1999;436-441.
10. Kramer A., Schneider-Mergener J. Synthesis and screening of peptide libraries on continuous cellulose membrane supports. Methods Mol. Biol. 87:1998;25-39.
11. Lai L., Kolber-Simonds D., Park K., Cheong H., Greenstein J., Im G., Samuel M., Bonk A., Rieke A., Day B., Murphy C., Carter D., Hawley R., Prather R. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science. 295:(5557):2002;1089-1092.
12. Lee J., Ihle J., Huebner R. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus. Proc. Natl. Acad. Sci. USA. 74:(1):1977;343-347.
13. Liao M., Lu Y., Xiao Y., Dierich M.P., Chen Y. Induction of high level of specific antibody response to the neutralizing epitope ELDKWA on HIV-1 gp41 by peptide-vaccine. Peptides. 21:(4):2000;463-468.
14. Liu M. Vaccine developments. Nature Med. 4:(5 Suppl.):1998;515-519.
15. Löwer R., Löwer J., Kurth R. The viruses in all of us characteristics and biological significance of human endogenous retrovirus sequences . Proc. Natl. Acad. Sci. USA. 93:(11):1996;5177-5184.
16. Lu Y., Xiao Y., Ding J., Dierich M.P., Chen Y.H. Multiepitope vaccines intensively increased levels of antibodies recognizing three neutralizing epitopes on human immunodeficiency virus-1 envelope protein. Scand. J. Immunol. 51:(5):2000;497-501.
17. Marciani D.J., Kensil C.R., Beltz G.A., Hung C.H., Cronier J., Aubert A. Genetically-engineered subunit vaccine against feline leukaemia virus protective immune response in cats . Vaccine. 9:(2):1991;89-96.
18. Montelaro, R. Bolognesi, D., 1995. Vaccines against retroviruses, in: Levy, J. A. (Ed.), The Retroviridae 4, Plenum Press, New York, NY, London, UK, pp. 605-656.
19. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:(11):1993;6642-6647.
20. Oldmixon B.A., Wood J.C., Ericsson T.A., Wilson C.A., White-Scharf M.E., Andersson G., Greenstein J.L., Schuurman H.J., Patience C. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J. Virol. 76:(6):2002;3045-3048.
21. Paradis K., Langford G., Long Z., Heneine W., Sandstrom P., Switzer W., Chapman L., Lockey C., Onions D., Otto E. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science. 285:(543):1999;1236-1241.
22. Patience C., Switzer W., Takeuchi Y., Griffiths D., Goward M., Heneine W., Stoye J., Weiss R. Multiple groups of novel retroviral genomes in pigs and related species. J. Virol. 75:(6):2001;2771-2775.
23. Patience C., Takeuchi Y., Weiss R. Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 3:(3):1997;282-286.
24. Peters R., Donahoe R., Kelloff G. Assay in the mouse for delayed-type hypersensitivity to murine leukemia virus. J. Natl. Cancer Inst. 55:(5):1975;1089-1095.
25. Schultz A., Stott E. Primate models for AIDS vaccines. AIDS. 8:(Suppl. 1):1994;203-212.
26. Schwarz, H., Thiel, H.J., Weinhold, K.J., Bolognesi, D.P., Schafer, W., 1984. Stimulation of immunoreactivity against endogenous retroviruses and protection against leukemia in aged AKR mice after vaccination with antibodies to viral surface components. The role of antibodies to p15(E). Z. Naturforsch. [C] 39(11-12), 1199-1202.
27. Sparkes A.H. Feline leukemia virus a review of immunity and vaccination . J. Small Anim. Pract. 38:(5):1997;187-194.
28. Specke V., Plesker R., Coulibaly C., Boller K., Denner J. Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) and lack of transmission to minks in vivo. Arch Virol. 147:(2):2002;305-319.
29. Specke V., Rubant S., Denner J. Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology. 285:(2):2001;177-180.
30. Specke V., Tacke S., Boller K., Schwendemann J., Denner J. Porcine endogenous retroviruses in vitro host range and attempts to establish small animal models . J. Gen. Virol. 82:(Pt.4):2001;837-844.
31. Tacke S., Bodusch K., Berg A., Denner J. Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation. 8:(2):2001;125-135.
32. Tacke S., Kurth R., Denner J. Porcine endogenous retroviruses inhibit human immune cell function risk for xenotransplantation? Virology. 268:(1):2000;87-93.
33. Tian H., Xiao Y., Zhu M., Chen Y.H. HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies. Int. Immunopharmacol. 1:(4):2001;763-768.
34. van der Laan L.J., Lockey C., Griffeth B.C., Frasier F.S., Wilson C.A., Onions D.E., Hering B.J., Long Z., Otto E., Torbett B.E., Salomon D.R. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature. 407:(6800):2000;90-94.
35. Wilson C., Wong S., Muller J., Davidson C., Rose T., Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Virol. 72:1998;3082-3087.
36. Wilson C., Wong S., VanBrocklin M., Federspiel M. Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J. Virol. 74:(1):2000;49-56.
37. Xiao Y., Zhao Y., Lu Y., Chen Y.H. Epitope-vaccine induces high levels of ELDKWA-epitope-specific neutralizing antibody. Immunol. Invest. 29:(1):2000;41-50.
38. Zwick M., Labrijn A., Wang M., Spenlehauer C., Saphire E., Binley J., Moore J., Stiegler G., Katinger H., Burton D., Parren P. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75:(22):2001;10892-10905.